Franklin Resources
TVTX icon

Franklin Resources’s Travere Therapeutics TVTX Stock Holding History

Franklin Resources’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54M Buy
132,794
+8,602
+7% +$381K ﹤0.01% 1397
2026
Q1 		$3.69M Buy
124,192
+30,490
+33% +$911K ﹤0.01% 1661
2025
Q4 		$3.58M Buy
93,702
+58,978
+170% +$1.92M ﹤0.01% 1554
2025
Q3 		$830K Sell
34,724
-41,787
-55% -$786K ﹤0.01% 2203
2025
Q2 		$1.13M Buy
76,511
+23,675
+45% +$392K ﹤0.01% 1936
2025
Q1 		$947K Buy
52,836
+16,598
+46% +$337K ﹤0.01% 1982
2024
Q4 		$631K Buy
+36,238
New +$641K ﹤0.01% 2186
2023
Q2 		– Sell
-422,961
Closed -$9.51M – 2765
2023
Q1 		$9.51M Buy
+422,961
New +$8.99M ﹤0.01% 939
2018
Q1 		– Sell
-880,450
Closed -$18.6M – 1548
2017
Q4 		$18.6M Sell
880,450
-158,900
-15% -$3.63M 0.01% 812
2017
Q3 		$25.9M Hold
1,039,350
– – 0.01% 724
2017
Q2 		$20.2M Hold
1,039,350
– – 0.01% 782
2017
Q1 		$19.2M Sell
1,039,350
-40,900
-4% -$800K 0.01% 795
2016
Q4 		$20.4M Sell
1,080,250
-23,900
-2% -$489K 0.01% 786
2016
Q3 		$24.7M Hold
1,104,150
– – 0.01% 745
2016
Q2 		$19.7M Sell
1,104,150
-163,800
-13% -$2.65M 0.01% 809
2016
Q1 		$17.3M Sell
1,267,950
-246,500
-16% -$3.74M 0.01% 842
2015
Q4 		$29.2M Sell
1,514,450
-42,700
-3% -$853K 0.01% 724
2015
Q3 		$31.5M Buy
1,557,150
+88,900
+6% +$2.63M 0.02% 712
2015
Q2 		$48.7M Buy
1,468,250
+257,800
+21% +$7.06M 0.02% 618
2015
Q1 		$29M Buy
+1,210,450
New +$18.5M 0.01% 795

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's TVTX Position: Q2 2026 in Review

Franklin Resources increased its Travere Therapeutics (TVTX) stake by 6.9% in Q2 2026, buying an estimated $381K and bringing the position to 132,794 shares worth $7.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Franklin Resources first reported a position in TVTX in Q1 2015 and has held it in 20 quarters since. The position peaked at $48.7M in Q2 2015. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Franklin Resources held 132,794 shares of Travere Therapeutics worth $7.54M as of Q2 2026.
  • Franklin Resources bought 8,602 Travere Therapeutics shares in Q2 2026, an estimated $381K.
  • Travere Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1397 holding.
  • Franklin Resources first reported a position in Travere Therapeutics in Q1 2015 and has held it in 20 quarters since.
  • Franklin Resources's Travere Therapeutics position peaked at $48.7M in Q2 2015.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.